Phase II Trial of Capecitabine and Weekly Docetaxel for Metastatic Castrate Resistant Prostate Cancer

Ulka N. Vaishampayan, Shanthi Marur, Lance K. Heilbrun, Michael L. Cher, Brenda Dickow, Daryn W. Smith, Samir A. Al Hasan, James Eliason

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II Trial of Capecitabine and Weekly Docetaxel for Metastatic Castrate Resistant Prostate Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences